Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Coppo

Showing results (171-180 of 199) with videos related to

Pageof 20
Sort By:
Journal of Thrombosis and Haemostasis : JTH|November 10, 2020
Immunogenic hotspots in the spacer domain of ADAMTS13 in immune-mediated thrombotic thrombocytopenic purpuraLeydi Carolina Velásquez Pereira, Elien Roose, Nuno A G Graça, et al.
Intensive Care Medicine|July 3, 2025
Thrombotic thrombocytopenic purpura: early diagnosis and effective treatment in 2025Elie Azoulay, Agnès Veyradier, Spero Cataland, et al.
Breast Cancer Research : BCR|January 20, 2021
Characteristics and outcome of breast cancer-related microangiopathic haemolytic anaemia: a multicentre studyMarion Alhenc-Gelas, Luc Cabel, Frederique Berger, et al.
Medicine|October 27, 2015
Risk Factors for Autoimmune Diseases Development After Thrombotic Thrombocytopenic PurpuraMélanie Roriz, Mickael Landais, Jonathan Desprez, et al.
Plos One|May 4, 2010
Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experiencePaul Coppo, Michael Schwarzinger, Marc Buffet, et al.
AIDS (London, England)|December 14, 2019
Hepatitis C virus or hepatitis B virus coinfection and lymphoma risk in people living with HIVCaroline Besson, Nicolas Noel, Remi Lancar, et al.
Blood|August 12, 2015
Severe chronic primary neutropenia in adults: report on a series of 108 patientsFlore Sicre de Fontbrune, Aline Moignet, Blandine Beaupain, et al.
Medicine|July 3, 2004
Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvementPaul Coppo, Djaouida Bengoufa, Agnès Veyradier, et al.
The New England Journal of Medicine|May 1, 2024
Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic PurpuraMarie Scully, Ana Antun, Spero R Cataland, et al.
Blood|September 12, 2018
Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpuraMatthieu Jestin, Ygal Benhamou, An-Sofie Schelpe, et al.
Pageof 20

Showing results (171-180 of 199) with videos related to

Sort By:
Pageof 20
Journal of Thrombosis and Haemostasis : JTH|November 10, 2020
Immunogenic hotspots in the spacer domain of ADAMTS13 in immune-mediated thrombotic thrombocytopenic purpuraLeydi Carolina Velásquez Pereira, Elien Roose, Nuno A G Graça, et al.
Intensive Care Medicine|July 3, 2025
Thrombotic thrombocytopenic purpura: early diagnosis and effective treatment in 2025Elie Azoulay, Agnès Veyradier, Spero Cataland, et al.
Breast Cancer Research : BCR|January 20, 2021
Characteristics and outcome of breast cancer-related microangiopathic haemolytic anaemia: a multicentre studyMarion Alhenc-Gelas, Luc Cabel, Frederique Berger, et al.
Medicine|October 27, 2015
Risk Factors for Autoimmune Diseases Development After Thrombotic Thrombocytopenic PurpuraMélanie Roriz, Mickael Landais, Jonathan Desprez, et al.
Plos One|May 4, 2010
Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experiencePaul Coppo, Michael Schwarzinger, Marc Buffet, et al.
AIDS (London, England)|December 14, 2019
Hepatitis C virus or hepatitis B virus coinfection and lymphoma risk in people living with HIVCaroline Besson, Nicolas Noel, Remi Lancar, et al.
Blood|August 12, 2015
Severe chronic primary neutropenia in adults: report on a series of 108 patientsFlore Sicre de Fontbrune, Aline Moignet, Blandine Beaupain, et al.
Medicine|July 3, 2004
Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvementPaul Coppo, Djaouida Bengoufa, Agnès Veyradier, et al.
The New England Journal of Medicine|May 1, 2024
Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic PurpuraMarie Scully, Ana Antun, Spero R Cataland, et al.
Blood|September 12, 2018
Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpuraMatthieu Jestin, Ygal Benhamou, An-Sofie Schelpe, et al.
Pageof 20